Evoke Wealth, LLC Novavax Inc Transaction History

Evoke Wealth, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$134.56 - $217.97 $1,480 - $2,397	-11 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $1,955 - $2,976	11 New	11 $2,000
Q2 2021 Aug 05, 2021	SELL	$121.0 - $257.67 $1,210 - $2,576	-10 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$112.98 - $319.93 $1,129 - $3,199	10 New	10 $2,000
Q4 2020 Feb 12, 2021	SELL	$78.74 - $139.5 $1,023 - $1,813	-13 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$79.44 - $178.51 $1,032 - $2,320	13 New	13 $1,000

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Evoke Wealth, LLC with notifications on news.